Role of Type I and II Interferons in Colorectal Cancer and Melanoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Type I and II Interferons in Colorectal Cancer and Melanoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-07-26
DOI
10.3389/fimmu.2017.00878
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
- (2017) Kai Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models
- (2017) Antonio Boccia et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage
- (2017) Elena Lo Presti et al. Cancer Immunology Research
- Mesenchymal stem cell: a new horizon in cancer gene therapy
- (2016) M Mohammadi et al. CANCER GENE THERAPY
- Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells
- (2016) Chih-Hang Anthony Tang et al. CANCER RESEARCH
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Reversing T-cell Dysfunction and Exhaustion in Cancer
- (2016) H. M. Zarour CLINICAL CANCER RESEARCH
- Dual Faces of IFN in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
- (2016) M. Mandai et al. CLINICAL CANCER RESEARCH
- Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
- (2016) Dionisia Quiroga et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Interview with Robert Coffin, inventor of T-VEC: the first oncolytic immunotherapy approved for the treatment of cancer
- (2016) Robert Coffin Immunotherapy
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer
- (2016) Maria Buoncervello et al. Oncotarget
- ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis
- (2016) Simone Di Franco et al. Oncotarget
- Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
- (2016) Tianli Xia et al. Cell Reports
- Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
- (2016) Yuliya V. Katlinskaya et al. Cell Reports
- The Role of Toll-Like Receptors in Hematopoietic Malignancies
- (2016) Darlene A. Monlish et al. Frontiers in Immunology
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer
- (2015) L. Corrales et al. CLINICAL CANCER RESEARCH
- The use of interferon in melanoma patients: A systematic review
- (2015) Rossella Di Trolio et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development
- (2015) Lu Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Diverse roles of STING-dependent signaling on the development of cancer
- (2015) J Ahn et al. ONCOGENE
- Going viral: a review of replication-selective oncolytic adenoviruses
- (2015) Christopher Larson et al. Oncotarget
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
- (2015) Kavitha Gowrishankar et al. PLoS One
- Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
- (2014) Michael J. White et al. CELL
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma
- (2014) M. Atefi et al. CLINICAL CANCER RESEARCH
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection
- (2014) Shivani Srivastava et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: STING Mediates Protection against Colorectal Tumorigenesis by Governing the Magnitude of Intestinal Inflammation
- (2014) Qifan Zhu et al. JOURNAL OF IMMUNOLOGY
- Interferons and Their Stimulated Genes in the Tumor Microenvironment
- (2014) HyeonJoo Cheon et al. SEMINARS IN ONCOLOGY
- The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1
- (2014) M G Mathieu et al. Cell Death & Disease
- Inflammation-driven carcinogenesis is mediated through STING
- (2014) Jeonghyun Ahn et al. Nature Communications
- Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
- (2014) T. Bald et al. Cancer Discovery
- PD-L1 Expression in Melanocytic Lesions Does Not Correlate with the BRAF V600E Mutation
- (2014) N. Rodi et al. Cancer Immunology Research
- Anticancer Flavonoids Are Mouse-Selective STING Agonists
- (2013) Sujeong Kim et al. ACS Chemical Biology
- IFN-γ selectively exerts pro-apoptotic effects on tumor-initiating label-retaining colon cancer cells
- (2013) Chao Ni et al. CANCER LETTERS
- Structure-Function Analysis of STING Activation by c[G(2′,5′)pA(3′,5′)p] and Targeting by Antiviral DMXAA
- (2013) Pu Gao et al. CELL
- Host Restriction Factor SAMHD1 Limits Human T Cell Leukemia Virus Type 1 Infection of Monocytes via STING-Mediated Apoptosis
- (2013) Alexandre Sze et al. Cell Host & Microbe
- Manipulating the PD-1 pathway to improve immunity
- (2013) Alice O Kamphorst et al. CURRENT OPINION IN IMMUNOLOGY
- Human NK Cells Selective Targeting of Colon Cancer-Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules
- (2013) R. Tallerico et al. JOURNAL OF IMMUNOLOGY
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
- (2013) J. Conlon et al. JOURNAL OF IMMUNOLOGY
- CD271 on Melanoma Cell Is an IFN-γ-Inducible Immunosuppressive Factor that Mediates Downregulation of Melanoma Antigens
- (2013) Junpei Furuta et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Colorectal cancer defeating? Challenge accepted!
- (2013) S. Di Franco et al. MOLECULAR ASPECTS OF MEDICINE
- Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models
- (2013) Bo-Rim Yi et al. Molecular Oncology
- STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease
- (2013) J. Petrasek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue Interactions in Neural Crest Cell Development and Disease
- (2013) Y. Takahashi et al. SCIENCE
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Impaired IFN- Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
- (2012) V. Sisirak et al. CANCER RESEARCH
- PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN- Inducible Chemokines
- (2012) W. Peng et al. CANCER RESEARCH
- Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
- (2012) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment--Poor Prognosis or New Therapeutic Opportunity
- (2012) L. A. Ridnour et al. CLINICAL CANCER RESEARCH
- Interleukin genes and associations with colon and rectal cancer risk and overall survival
- (2012) Kristina L. Bondurant et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer and Innate Immune System Interactions
- (2012) Yanan Liu et al. JOURNAL OF IMMUNOTHERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
- (2012) J. Wu et al. SCIENCE
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival
- (2011) Martha L. Slattery et al. CARCINOGENESIS
- CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2011) C. Zoglmeier et al. CLINICAL CANCER RESEARCH
- Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer
- (2011) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Stochastic Receptor Expression Determines Cell Fate upon Interferon Treatment
- (2011) D. Levin et al. MOLECULAR AND CELLULAR BIOLOGY
- Interferon-γ links ultraviolet radiation to melanomagenesis in mice
- (2011) M. Raza Zaidi et al. NATURE
- Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown
- (2011) Simone Di Franco et al. Cancers
- Interferon limits the effectiveness of melanoma peptide vaccines
- (2010) H.-I. Cho et al. BLOOD
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Inflammatory cytokines as a third signal for T cell activation
- (2010) Julie M Curtsinger et al. CURRENT OPINION IN IMMUNOLOGY
- Interferon-α targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway
- (2010) Min Lu et al. EXPERIMENTAL HEMATOLOGY
- APC Activation by IFN- Decreases Regulatory T Cell and Enhances Th Cell Functions
- (2010) L. Pace et al. JOURNAL OF IMMUNOLOGY
- Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
- (2010) Alexander D. Boiko et al. NATURE
- Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages
- (2009) Dorothée Duluc et al. INTERNATIONAL JOURNAL OF CANCER
- The Impact of PEGylation on Biological Therapies
- (2008) Francesco M Veronese et al. BIODRUGS
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
- (2008) K. S. Hoek et al. CANCER RESEARCH
- Roles of TGFβ in metastasis
- (2008) David Padua et al. CELL RESEARCH
- Plasmacytoid dendritic cells induce NK cell–dependent, tumor antigen–specific T cell cross-priming and tumor regression in mice
- (2008) Chengwen Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
- (2008) Alexander MM Eggermont et al. LANCET
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
- Efficient tumour formation by single human melanoma cells
- (2008) Elsa Quintana et al. NATURE
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
- (2008) Roberto Cattaneo et al. NATURE REVIEWS MICROBIOLOGY
- Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells
- (2008) R Chen et al. ONCOGENE
- HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
- (2008) M Campoli et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started